Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Clinical trial NCT07416188 · RECRUITING

Trial details

NCT number: NCT07416188
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Glioblastoma Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype Relapsed Cancer Recurrent Tumor Glioblastoma Multiforme Recurring Glioblastoma Brain and Central Nervous System Tumors Glioma Glioblastomas Grade IV Astrocytoma GBM Recurrent Glioma (Glioblastoma Multiforme)

Start date: 2026-07-15
Primary completion: 2030-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.